Efficacy and Mechanism of Qianshan Huoxue Gao in Acute Coronary Syndrome via Regulation of Intestinal Flora and Metabolites
Drug Design, Development and Therapy · 2023
DOI: 10.2147/dddt.s396649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Ning Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Gastrointestinal Microbiome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
To study the efficacy of Qianshan Huoxue Gao (QS) in treating acute coronary syndrome (ACS) and to explore the mechanism of action from the perspective of intestinal flora regulation.
Methods
Male Sprague-Dawley rats were divided into control, model, QS, and atorvastatin groups; except for the control group, rats underwent ligation of the left anterior descending branch of the coronary artery. Following treatment for 28 days, cardiac function was evaluated using an echocardiographic assay; ELISAs for serum creatine kinase isoenzyme (CK-MB), cardiac troponin I (cTnI), high-sensitivity C-reactive protein (hs-CRP), interleukin (IL)-2 (IL-2), IL-6, and tumor necrosis factor-α (TNF-α); assessment of cardiac enzymes and inflammatory response; hematoxylin and eosin (HE) staining for histopathological changes in the heart, skin, and viscera; 16S rRNA gene sequencing for intestinal flora diversity and structural differences analysis; and we further investigated intestinal contents using metabolomics.
Results
Compared with controls, CK-MB and cTnI were increased (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China.
- Formula-Syndrome Research Center, Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China.
- Department of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria.
- Beijing Xiuzheng Pharmaceutical Company, Beijing, People's Republic of China.
- Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria.
ORCID-Profile: Ning Zhao, Dacheng Hong
Zitieren
APA
Zhao, N., Ma, Y., Liang, X., Zhang, Y., Hong, D., Wang, Y., & Bai, D. (2023). Efficacy and Mechanism of Qianshan Huoxue Gao in Acute Coronary Syndrome via Regulation of Intestinal Flora and Metabolites. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s396649
Vancouver
Zhao N, Ma Y, Liang X, Zhang Y, Hong D, Wang Y, et al. Efficacy and Mechanism of Qianshan Huoxue Gao in Acute Coronary Syndrome via Regulation of Intestinal Flora and Metabolites. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s396649
BibTeX
@article{Zhao2023,
author = {Zhao, Ning and Ma, Yan and Liang, Xiaoxue and Zhang, Yu and Hong, Dacheng and Wang, Ying and Bai, Dong},
title = {Efficacy and Mechanism of Qianshan Huoxue Gao in Acute Coronary Syndrome via Regulation of Intestinal Flora and Metabolites},
journal = {Drug Design, Development and Therapy},
year = {2023},
doi = {10.2147/dddt.s396649}
}
EUVIMED